KEPPRA 250 mg, film-coated tablet 60 tablets, parallel import (Mediwin)
Brand page: Keppra (levetiracetam) — all forms and strengths in France
Active ingredients: (S)-etiracetam
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet60 tablets, parallel import (Mediwin)orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KEPPRA 250 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 60 comprimé(s) (distributeur parallèle : Mediwin)
- Marketing authorisation holder
- UCB PHARMA BELGIQUE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Aug 2015
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65586187CIP74950006CIP133400949500062Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVÉTIRACÉTAMcomprimé | 250 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.